Michael A. Erb
Impact in
- Molecular Biology top 2%
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Genomics and Chromatin Dynamics
- Histone Deacetylase Inhibitors Research
- Muscle Physiology and Disorders
- RNA Research and Splicing
- Hematology top 5%
- Multiple Myeloma Research and Treatments
Papers in
-
- Protein Degradation and Inhibitors 16
- Ubiquitin and proteasome pathways 14
- Histone Deacetylase Inhibitors Research 8
- Muscle Physiology and Disorders 6
- RNA Interference and Gene Delivery 5
-
- Infective Endocarditis Diagnosis and Management 4
- Co-authors
- James E. Bradner (10 shared papers)Georg E. Winter (9 shared papers)Nathanael S. Gray (4 shared papers)Joshiawa Paulk (5 shared papers)Thomas G. Scott (6 shared papers)Dennis L. Buckley (5 shared papers)Matthew A. Lawlor (3 shared papers)Behnam Nabet (4 shared papers)
- Journals
- The Thoracic and Cardiovascular Surgeon (7 papers)Nature Chemical Biology (4 papers)PLoS ONE (3 papers)ACS Chemical Biology (3 papers)Scientific Reports (2 papers)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Michael A. Erb
48 papers receiving 3.0k citations
Michael A. Erb's Hit Papers
Peers
Comparison fields: 5 of 115
- Molecular Biology 2.5k
- Hematology 315
- Oncology 545
- Genetics 107
- Developmental Neuroscience 35
Countries citing papers authored by Michael A. Erb
This map shows the geographic impact of Michael A. Erb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Erb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Erb more than expected).
Fields of papers citing papers by Michael A. Erb
This network shows the impact of papers produced by Michael A. Erb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Erb. The network helps show where Michael A. Erb may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael A. Erb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The dTAG system for immediate and target-specific protein degradation Hit paper breakdown → | 2018 | 682 |
| 2 | Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation Hit paper breakdown → | 2017 | 412 |
| 3 | 2017 | 207 | |
| 4 | 2017 | 190 | |
| 5 | 2018 | 172 | |
| 6 | 2011 | 154 | |
| 7 | 2018 | 134 | |
| 8 | 2018 | 134 | |
| 9 | 2012 | 94 | |
| 10 | 2008 | 82 | |
| 11 | 2012 | 76 | |
| 12 | 2009 | 73 | |
| 13 | 2021 | 65 | |
| 14 | 2008 | 43 | |
| 15 | 2011 | 42 | |
| 16 | 2020 | 41 | |
| 17 | 2021 | 39 | |
| 18 | 2006 | 37 | |
| 19 | 2018 | 35 | |
| 20 | 2006 | 33 |
About Michael A. Erb
Michael A. Erb is a scholar working on Molecular Biology, Epidemiology, Cell Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine, having authored 51 papers that have together received 3.0k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (16 papers), Ubiquitin and proteasome pathways (14 papers), Histone Deacetylase Inhibitors Research (8 papers), Muscle Physiology and Disorders (6 papers), RNA Interference and Gene Delivery (5 papers), Infective Endocarditis Diagnosis and Management (4 papers), Calpain Protease Function and Regulation (3 papers) and Cardiac Valve Diseases and Treatments (3 papers). The work is most often cited by research in Molecular Biology (2.5k citations), Hematology (315 citations), Oncology (545 citations), Genetics (107 citations) and Developmental Neuroscience (35 citations). Michael A. Erb has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include James E. Bradner, Georg E. Winter, Nathanael S. Gray, Joshiawa Paulk, Thomas G. Scott, Dennis L. Buckley, Matthew A. Lawlor, Behnam Nabet, Jun Qi and Jennifer A. Perry. Their work appears in journals such as The Thoracic and Cardiovascular Surgeon, Nature Chemical Biology, PLoS ONE, ACS Chemical Biology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.